These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28146139)

  • 1. Is cardiovascular risk in women with PCOS a real risk? Current insights.
    Papadakis G; Kandaraki E; Papalou O; Vryonidou A; Diamanti-Kandarakis E
    Minerva Endocrinol; 2017 Dec; 42(4):340-355. PubMed ID: 28146139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
    Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
    Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
    J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome and cardiovascular disease: a premature association?
    Legro RS
    Endocr Rev; 2003 Jun; 24(3):302-12. PubMed ID: 12788801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach.
    Ravn P
    Minerva Ginecol; 2015 Apr; 67(2):217-23. PubMed ID: 25668421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
    Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
    Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.
    Sirmans SM; Weidman-Evans E; Everton V; Thompson D
    Ann Pharmacother; 2012 Mar; 46(3):403-18. PubMed ID: 22388330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome.
    Armeni E; Lambrinoudaki I
    Curr Vasc Pharmacol; 2019; 17(6):579-590. PubMed ID: 30156159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not all women diagnosed with PCOS share the same cardiovascular risk profiles.
    Jovanovic VP; Carmina E; Lobo RA
    Fertil Steril; 2010 Aug; 94(3):826-32. PubMed ID: 19501355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
    Daskalopoulos GN; Karkanaki A; Karagiannis A; Mikhailidis DP; Athyros VG
    Angiology; 2011 May; 62(4):285-90. PubMed ID: 21474465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular system diseases in patients with polycystic ovary syndrome - the role of inflammation process in this pathology and possibility of early diagnosis and prevention.
    Marciniak A; Nawrocka Rutkowska J; Brodowska A; Wiśniewska B; Starczewski A
    Ann Agric Environ Med; 2016 Dec; 23(4):537-541. PubMed ID: 28030919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
    Cussons AJ; Stuckey BG; Watts GF
    Atherosclerosis; 2006 Apr; 185(2):227-39. PubMed ID: 16313910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic consequences of polycystic ovary syndrome.
    Churchill SJ; Wang ET; Pisarska MD
    Minerva Ginecol; 2015 Dec; 67(6):545-55. PubMed ID: 26372304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.